Breaking Finance News

Transenterix Inc (NASDAQ:TRXC) target price raised to $0.70, reported today by B. Riley

Having a price of $0.52, Transenterix Inc (NASDAQ:TRXC) traded -1.66% lower on the day. With the last close down -59.89% from the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.02% over the same period. TRXC has recorded a 50-day average of $0.98 and a two hundred day average of $1.30. Trade Volume was down over the average, with 477,581 shares of TRXC changing hands under the typical 993,436

Transenterix Inc (NASDAQ:TRXC) had its price target upped to $0.70 by B. Riley in an issued report issued 5/16/2017. The upped price target implies a potential upside of 0.35% from the company's previous close.

Recent Performance Chart

Transenterix Inc (NASDAQ:TRXC)

Transenterix Inc has with a one year low of $0.52 and a one year high of $2.33 and has a market capitalization of $0.

A total of 7 analysts have released a report on Transenterix Inc. Three analysts rating the company a strong buy, four analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $4.04.

General Company Details For Transenterix Inc (NASDAQ:TRXC)

TransEnterix, Inc. is a medical device company. The Company is focused on the development and commercialization of ALF-X Surgical Robotic System (the ALF-X System), and SurgiBot System. The Company's ALF-X System is a multi-port robotic surgery system, which allows multiple robotic arms to control instruments and a camera. The system features advanced technology to enable surgeons with haptic feedback and the ability to move the camera through eye movement. The system replicates laparoscopic motion and integrates three-dimensional high definition (3DHD) vision technology. The ALF-X System also offers responsible economics to hospitals by offering robotic technology with reusable instruments. The SurgiBot System is designed as a single-incision, patient-side robotic-assisted surgery system. The Company also develops and manufactures laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.